The present invention refers to a polypeptide comprising at least one first domain for binding to at least one contrast agent and at least one second domain for binding to at least one target structure-binding compound. Furthermore, the invention relates to said polypeptide for use in a method for the diagnosis of a patient. Moreover, the present invention embraces means and methods for producing said polypeptide and to in vivo and in vitro uses thereof.
